Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Huawei EV partner Seres prepares up to $2bn Hong Kong listing amid IPO revival
Huawei EV partner Seres prepares up to $2bn Hong Kong listing amid IPO revival Seres Group Co., the Chinese electric vehicle maker backed by Huawei Technologies, is gauging investor interest for a Hong Kong listing expected to raise between $1.5bn and $2bn, according...
JPMorgan targets $600bn Asia-Pacific expansion amid rising institutional demand
JPMorgan targets $600bn Asia-Pacific expansion amid rising institutional demand JPMorgan Asset Management plans to double its Asia-Pacific assets under management to $600bn over the next five years, strengthening its position in one of the fastest-growing regions for...
Invalda INVL raises investment in €410m private equity fund to €34m
Invalda INVL raises investment in €410m private equity fund to €34m Invalda INVL has increased its commitment to the INVL Private Equity Fund II to €34.16m, following an additional €3.33m allocation approved by its management board on 14 October. The fund, managed by...